Phillips-Medisize said this week that it teamed up with healthcare software tech company InterSystems to develop a data-sharing and analytics platform designed for connected drug-delivery devices and mobile medical apps.
The third-generation of Phillips-Medisize’s connected health platform, combined with InterSystems’ HealthShare platform, will allow pharma companies to connect medication and diagnostic data across their drugs and therapeutic areas on a single system.
“Our collaboration with InterSystems brings together the information that matters – connecting pharmaceutical companies, providers, patients, and payers on the Phillips-Medisize Connected Health Platform through a unified healthcare medication record and powerful analytics that span the care continuum,” Matt Jennings, president & CEO of Phillips-Medisize, said in prepared remarks.
Data collected by devices using the Phillips-Medisize connected health platform can be securely shared with both patients and healthcare providers. Pharmaceutical companies working with Phillips-Medisize are slated to receive an exclusive, secure private cloud, according to the company.
“Poor medication adherence currently yields unnecessary human suffering and significantly reduced patient health around the world. The collaboration between InterSystems and Phillips-Medisize aims to change that paradigm with a highly scalable platform to securely connect and aggregate data from rare diseases to many millions of patients across global geographies; encouraging patients in the most effective use of prescribed medications to improve outcomes,” Don Woodlock, head of the HealthShare business unit at InterSystems, added.
Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.